Voloridge Investment Management
GBT

Voloridge Investment Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Voloridge Investment Management’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-59,113
Closed -$2.05M – 1697
2022
Q1 		$2.05M Sell
59,113
-136,253
-70% -$4.07M 0.01% 940
2021
Q4 		$5.72M Sell
195,366
-223,197
-53% -$6.91M 0.03% 671
2021
Q3 		$10.7M Buy
418,563
+75,387
+22% +$2.22M 0.07% 407
2021
Q2 		$12M Buy
343,176
+58,221
+20% +$2.27M 0.08% 341
2021
Q1 		$11.6M Sell
284,955
-56,628
-17% -$2.6M 0.08% 311
2020
Q4 		$14.8M Buy
341,583
+311,657
+1,041% +$15.4M 0.12% 199
2020
Q3 		$1.65M Buy
+29,926
New +$1.9M 0.01% 781
2020
Q1 		– Sell
-38,423
Closed -$3.05M – 1494
2019
Q4 		$3.05M Buy
+38,423
New +$2.28M 0.06% 393
2018
Q2 		– Sell
-38,806
Closed -$1.87M – 650
2018
Q1 		$1.87M Buy
+38,806
New +$2.16M 0.04% 286
2017
Q2 		– Sell
-90,655
Closed -$3.34M – 625
2017
Q1 		$3.34M Buy
+90,655
New +$2.28M 0.08% 268

Other funds holding GBT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Voloridge Investment Management's GBT Position: Q2 2022 in Review

Voloridge Investment Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q2 2022, closing a stake of 59,113 shares — an estimated $2.05M sold.

Voloridge Investment Management first reported a position in GBT in Q1 2017 and held it in 10 quarters. The position peaked at $14.8M in Q4 2020. 195 funds tracked by Wall St. Rank hold GBT as of Q2 2022.

  • Voloridge Investment Management reported no remaining Global Blood Therapeutics, Inc. position as of Q2 2022 after selling out during the quarter.
  • Voloridge Investment Management sold 59,113 Global Blood Therapeutics, Inc. shares in Q2 2022, an estimated $2.05M.
  • Voloridge Investment Management first reported a position in Global Blood Therapeutics, Inc. in Q1 2017 and held it in 10 quarters.
  • Voloridge Investment Management's Global Blood Therapeutics, Inc. position peaked at $14.8M in Q4 2020.
  • 195 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q2 2022.

Based on Voloridge Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.